Clinical suspicion, diagnosis and management of cardiac amyloidosis: update document and executive summary.
Rev Clin Esp (Barc)
; 224(5): 288-299, 2024 May.
Article
de En
| MEDLINE
| ID: mdl-38614320
ABSTRACT
In recent years, the interest in cardiac amyloidosis has grown exponentially. However, there is a need to improve our understanding of amyloidosis in order to optimise early detection systems. Therefore, it is crucial to incorporate solutions to improve the suspicion, diagnosis and follow-up of cardiac amyloidosis. In this sense, we designed a tool following the different phases to reach the diagnosis of cardiac amyloidosis, as well as an optimal follow-up a) clinical suspicion, where the importance of the "red flags" to suspect it and activate the diagnostic process is highlighted; 2) diagnosis, where the diagnostic algorithm is mainly outlined; and 3) follow-up of confirmed patients. This is a practical resource that will be of great use to all professionals caring for patients with suspected or confirmed cardiac amyloidosis, to improve its early detection, as well as to optimise its accurate diagnosis and optimal follow-up.
Mots clés
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Sujet principal:
Amyloïdose
/
Cardiomyopathies
Limites:
Humans
Langue:
En
Journal:
Rev Clin Esp (Barc)
Année:
2024
Type de document:
Article
Pays de publication:
Espagne